Home
Discover
Trends
Leaders
Trending Assets
Top investors this month
Trending Assets
Top investors this month
PostsTradesAbout
Statistics
Open-/-
High-/-
Low-/-
Volume-/-
Mkt Cap-/-
P/E Ratio-/-
52w High-/-
52w Low-/-
Avg Vol-/-
Yield-/-
Beta0.00
EPS-0.44
Data delayed by 15 minutes.
Categories
Health Technology
Biotechnology
Manufacturing
Pharmaceutical Preparation Manufacturing
About
ChemoCentryx is a biopharmaceutical company developing new medications for inflammatory and autoimmune diseases and cancer. ChemoCentryx targets the chemokine and chemoattractant systems to discover, develop and commercialize orally-administered therapies.
CEOThomas Schall
HQMountain View, California
Employees133
Asset statistics
Commonstock is a social network that amplifies the knowledge of the best investors, verified by actual track records for signal over noise. Community members can link their existing brokerage accounts and share their real time portfolio, performance and trades (by percent only, dollar amounts never shared). Commonstock is not a brokerage, but a social layer on top of existing brokerages helping to create more engaged and informed investors.
AboutBlogCareersBrand Kit
Terms of ServiceCopyright PolicyPrivacy PolicySecurity
Already have an account?